Evidence map›Paper›PMID 35923906›Full record

ArticleJournal of inflammation research2022

IFN-γ and LPS Induce Synergistic Expression of CCL2 in Monocytic Cells via H3K27 Acetylation.

Nadeem Akhter, Shihab Kochumon, Amal Hasan, Ajit Wilson, Rasheeba Nizam, Ashraf Al Madhoun, Fatema Al-Rashed, Hossein Arefanian, Fawaz Alzaid, Sardar Sindhu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of inflammation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Maternal Nutrition, Toxicants, and Epigenetic Programming of Obesity Across Generations.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Nadeem AkhterImmunology & Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.
Shihab KochumonImmunology & Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.
Amal HasanImmunology & Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.ORCID 0000-0002-1793-7794
Ajit WilsonImmunology & Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.
Rasheeba NizamGenetics & Bioinformatics, Dasman Diabetes Institute, Kuwait City, Kuwait.
Ashraf Al MadhounGenetics & Bioinformatics, Dasman Diabetes Institute, Kuwait City, Kuwait.ORCID 0000-0001-8593-3878
Fatema Al-RashedImmunology & Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.ORCID 0000-0002-5825-7701
Hossein ArefanianImmunology & Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.ORCID 0000-0001-6414-0916
Fawaz AlzaidGenetics & Bioinformatics, Dasman Diabetes Institute, Kuwait City, Kuwait.
Sardar SindhuImmunology & Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.ORCID 0000-0001-9936-1575
Fahd Al-MullaImmunology & Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.ORCID 0000-0001-5409-3829
Rasheed AhmadImmunology & Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.ORCID 0000-0001-5746-0743
Dasman Diabetes Institute · KWInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Overexpression of CCL2 (MCP-1) has been implicated in pathogenesis of metabolic conditions, such as obesity and T2D. However, the mechanisms leading to increased CCL2 expression in obesity are not fully understood. Since both IFN-γ and LPS levels are found to be elevated in obesity and shown to be involved in the regulation of metabolic inflammation and insulin resistance, we investigated whether these two agents could synergistically trigger the expression of CCL2 in obesity. Methods: Monocytes (Human monocytic THP-1 cells) were stimulated with IFN-γ and LPS. CCL2 gene expression was determined by real-time RT-PCR. CCL2 protein was determined by ELISA. Signaling pathways were identified by using epigenetic inhibitors and STAT1 siRNA. Acetylation of H3K27 was analyzed by Western blotting. The acetylation level of histone H3K27 in the transcriptional initiation region of CCL2 gene was determined by ChIP-qPCR. Results: Our results show that the co-incubation of THP-1 monocytes with IFN-γ and LPS significantly enhanced the expression of CCL2, compared to treatment with IFN-γ or LPS alone. Similar results were obtained using primary monocytes and macrophages. Interestingly, IFN-γ priming was found to be more effective than LPS priming in inducing synergistic expression of CCL2. Moreover, STAT1 deficiency significantly suppressed this synergy for CCL2 expression. Mechanistically, we showed that IFN-γ priming induced acetylation of lysine 27 on histone 3 (H3K27ac) in THP-1 cells. Chromatin immunoprecipitation (ChIP) assay followed by qRT-PCR revealed increased H3K27ac at the CCL2 promoter proximal region, resulting in stabilized gene expression. Furthermore, inhibition of histone acetylation with anacardic acid suppressed this synergistic response, whereas trichostatin A (TSA) could substitute IFN-γ in this synergy. Conclusion: Our findings suggest that IFN-γ, in combination with LPS, has the potential to augment inflammation via the H3K27ac-mediated induction of CCL2 in monocytic cells in the setting of obesity.

Indexed as

CCL2H3K27 acIFN-γinflammationLPSmonocytes/macrophages

Identifiers

PMID35923906
PMCPMC9343018
OpenAlexW4288047131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.